SCHEDULE OF REPORTABLE SEGMENT LOSS |
The
following table presents reportable segment loss, including significant expenses regularly provided to the CODM, attributable to the
Company’s reportable segment for the periods presented:
SCHEDULE OF REPORTABLE SEGMENT LOSS
| |
$ | 1 | | |
$ | 2 | | |
$ | 3 | | |
$ | 4 | |
| |
Three
months ended | | |
Six
months ended | |
| |
June
30 | | |
June
30 | |
| |
2025 | | |
2024 | | |
2025 | | |
2024 | |
Research
and development: | |
| | | |
| | | |
| | | |
| | |
External
research and development | |
$ | 1,687,877 | | |
$ | 923,864 | | |
$ | 4,003,989 | | |
$ | 1,704,764 | |
Internal
personnel costs | |
| 479,237 | | |
| 790,109 | | |
| 973,965 | | |
| 1,600,351 | |
Total research
and development | |
| 2,167,114 | | |
| 1,713,973 | | |
| 4,977,954 | | |
| 3,305,115 | |
General and
administrative | |
| 2,289,649 | | |
| 2,394,912 | | |
| 4,051,368 | | |
| 4,747,009 | |
Other income,
net | |
| (15,547 | ) | |
| (93,618 | ) | |
| (55,676 | ) | |
| (230,180 | ) |
Change
in fair value of convertible promissory notes | |
| 787,703 | | |
| - | | |
| 787,703 | | |
| - | |
Net
loss | |
$ | 5,228,919 | | |
$ | 4,015,267 | | |
$ | 9,761,349 | | |
$ | 7,821,944 | |
|